# Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea

> **NCT06620510** · — · COMPLETED · sponsor: **GC Cell Corporation** · enrollment: 230 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** Immuncell-LC
- **BIOLOGICAL:** No Interventions

## Key facts

- **NCT ID:** NCT06620510
- **Lead sponsor:** GC Cell Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-30
- **Primary completion:** 2024-12-05
- **Final completion:** 2025-06-13
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620510, "Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06620510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*